Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0178874 (
tumor progression
)
40,807
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Forkhead box C1 (FOXC1) is a transcription factor that serves an important role in regulating tumorigenesis and
cancer progression
. However, the expression and functional role of FOXC1 in oral squamous cell carcinoma (OSCC) remains unclear.
FOXC1 protein
expression was determined using immunohistochemical staining of OSCC tissues and normal tissues. Cell Counting Kit-8, colony formation, migration and 5-ethynyl-2'-deoxyuridine assays were performed to investigate the role and underlying mechanism of action of FOXC1 in OSCC. A consistent increase in the immunoreactive intensity of FOXC1 in OSCC tissues as compared with that in adjacent normal tissues was demonstrated. Knockdown of
FOXC1
impaired cell growth and colony formation by inhibiting cell proliferation and reducing cyclin B1 and cyclin D1 levels in OSCC cells.
FOXC1
-silenced OSCC cells exhibited decreased migration compared with that demonstrated by the control cells, accompanied by a downregulation of matrix metalloproteinase (MMP)-2 and MMP-9. Collectively, the results of the present study demonstrated that
FOXC1
functions as an oncogene in OSCC and may be an important therapeutic target and predictive biomarker for OSCC.
...
PMID:Silencing FOXC1 inhibits growth and migration of human oral squamous cell carcinoma cells. 3023 83